Published in Infect Immun on October 01, 2005
Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity (2008) 1.65
Natural killer cells in infection and inflammation of the lung. Immunology (2009) 1.46
Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am J Respir Crit Care Med (2010) 1.10
Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One (2010) 0.99
Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Immunology (2009) 0.95
Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun (2006) 0.93
Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia. Infect Immun (2007) 0.90
Immunology of tuberculosis. World J Exp Med (2012) 0.79
Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease. J Infect Dis (2010) 0.78
NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization. J Immunol (2009) 0.77
THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE. Curr Trends Immunol (2009) 0.77
Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses. PLoS One (2016) 0.75
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
The many faces of macrophage activation. J Leukoc Biol (2003) 8.95
Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol (1983) 5.73
EXPERIMENTAL INFECTION WITH MYCOPLASMA PNEUMONIAE (EATON'S AGENT). J Exp Med (1965) 5.36
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med (2001) 3.63
The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol (2001) 3.21
Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis (1979) 3.12
Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors. J Exp Med (1984) 3.06
The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells. J Exp Med (1971) 2.92
Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis (1993) 2.45
Role of chemokines in the biology of natural killer cells. J Leukoc Biol (2002) 2.34
A link between chronic asthma and chronic infection. J Allergy Clin Immunol (2001) 2.18
Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol (2003) 2.17
Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol (1997) 2.08
In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol (2002) 2.04
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun (2002) 1.85
Cytokines and macrophages. Biomed Pharmacother (1994) 1.60
Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol (1999) 1.51
Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect Immun (1995) 1.50
IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol (1996) 1.50
Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun (1985) 1.49
Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun (1998) 1.44
Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol (1998) 1.43
Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol (2001) 1.38
Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect Immun (1995) 1.36
Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect Immun (1980) 1.35
Studies on attachment and ingestion phases of phagocytosis of Mycoplasma pulmonis by mouse peritoneal macrophages. Proc Soc Exp Biol Med (1972) 1.33
Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J Immunol (1998) 1.31
Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect Immun (1987) 1.26
Induction of IFN-gamma-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guérin. Eur J Immunol (1999) 1.26
Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect Immun (1997) 1.24
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J Infect Dis (2003) 1.20
Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. J Med Microbiol (1974) 1.18
Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology (2000) 1.18
Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol (2002) 1.14
Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am J Physiol (1998) 1.12
Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J Exp Med (1997) 1.10
Resistance to Mycoplasma pulmonis mediated by activated natural killer cells. J Infect Dis (1990) 1.09
Decreased intrapulmonary killing of Mycoplasma pulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages. Am Rev Respir Dis (1992) 1.06
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. Clin Exp Immunol (2003) 1.05
The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol (2003) 1.05
IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J Immunol (2003) 1.04
Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions. Am J Physiol Lung Cell Mol Physiol (2001) 1.02
The upper and lower respiratory tracts differ in their requirement of IFN-gamma and IL-4 in controlling respiratory mycoplasma infection and disease. J Immunol (2004) 1.00
Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes. J Med Microbiol (1980) 0.98
Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis. Am Rev Respir Dis (1989) 0.98
Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis. Clin Exp Immunol (1994) 0.96
Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice. Infect Immun (2001) 0.95
Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem Pharmacol (2000) 0.95
Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation (2000) 0.94
Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease. J Infect Dis (2002) 0.93
Effect of T-cell deficiency on the chronicity of arthritis induced in mice by Mycoplasma pulmonis. Infect Immun (1980) 0.92
Mycoplasma pulmonis infection augments natural killer cell activity in mice. Lab Anim Sci (1987) 0.91
Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils. Int J Antimicrob Agents (2004) 0.89
Role of innate immunity in respiratory mycoplasma infection. Front Biosci (2002) 0.87
Delayed hypersensitivity in mycoplasma pneumoniae infections. Lancet (1971) 0.86
Mycoplasma arthritidis mitogen up-regulates human NK cell activity. Infect Immun (1996) 0.85
Helper T cell differentiation, inside and out. Curr Opin Immunol (2001) 0.85
Cytokine modulators for allergic diseases. Curr Opin Allergy Clin Immunol (2001) 0.85
Modulation of granulocyte colony-stimulating factor receptors on murine peritoneal exudate macrophages by tumor necrosis factor-alpha. J Immunol (1991) 0.84
Interaction of mycoplasmas and phagocytes. Yale J Biol Med (1984) 0.83
T lymphocyte responses are critical determinants in the pathogenesis and resistance to mycoplasma respiratory disease. Front Biosci (2003) 0.82
Dendritic cells are present in the alveolar region of lungs from specific pathogen-free rats. Reg Immunol (1992) 0.82
Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity. J Immunol (1994) 0.81
Attachment and ingestion of mycoplasmas by mouse macrophages. II. Scanning electron microscopic observations. Am J Pathol (1977) 0.81
Attachment and ingestion of mycoplasmas by mouse macrophages. I. Kinetics of the interaction and effects on phagocyte glucose metabolism. Am J Pathol (1977) 0.80
Lysis by RNK-16 cytotoxic lymphocyte granules. Rate assays and conditions to study control of cytolysis. J Immunol Methods (1988) 0.78
Perforin-enhancing protein, a low molecular weight protein of cytotoxic lymphocyte granules, enhances perforin lysis. Biochem Biophys Res Commun (1997) 0.77
Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J Bacteriol (2002) 3.41
Peri- and intra-operative management of the goat during acute surgical experimentation. Lab Anim (NY) (2010) 2.19
Catabolite repression of Escherichia coli biofilm formation. J Bacteriol (2002) 1.70
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol (2008) 1.57
Abdominal lymphatic pump treatment increases leukocyte count and flux in thoracic duct lymph. Lymphat Res Biol (2007) 1.22
Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol (2002) 1.14
Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis. PLoS Pathog (2011) 1.10
Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252. Antimicrob Agents Chemother (2013) 1.06
The upper and lower respiratory tracts differ in their requirement of IFN-gamma and IL-4 in controlling respiratory mycoplasma infection and disease. J Immunol (2004) 1.00
Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One (2010) 0.99
A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol (2009) 0.96
Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease. J Infect Dis (2002) 0.93
Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination. Vaccine (2002) 0.91
Oral inoculation of young dairy calves with Mycoplasma bovis results in colonization of tonsils, development of otitis media and local immunity. PLoS One (2012) 0.90
Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity. Arch Biochem Biophys (2002) 0.90
IL-4-independent pathways exacerbate methacholine-induced airway hyperreactivity during mycoplasma respiratory disease. J Allergy Clin Immunol (2004) 0.87
Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C). Arch Biochem Biophys (2004) 0.86
Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease. Am J Transplant (2005) 0.85
T lymphocyte responses are critical determinants in the pathogenesis and resistance to mycoplasma respiratory disease. Front Biosci (2003) 0.82
IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells. J Immunol (2003) 0.81
Corticotropin-releasing hormone receptor-1 and 2 activity produces divergent resistance against stress-induced pulmonary Streptococcus pneumoniae infection. J Neuroimmunol (2011) 0.79
Pyruvate-fortified fluid resuscitation improves hemodynamic stability while suppressing systemic inflammation and myocardial oxidative stress after hemorrhagic shock. Mil Med (2010) 0.79
Lipid-dependent cytotoxicity by the lipase PLRP2 and by PLRP2-positive cytotoxic T lymphocytes (CTLs). Cell Biochem Funct (2009) 0.78
Interleukin-23 (IL-23) deficiency disrupts Th17 and Th1-related defenses against Streptococcus pneumoniae infection. Cytokine (2013) 0.78
Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease. J Infect Dis (2010) 0.78
THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE. Curr Trends Immunol (2009) 0.77
NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization. J Immunol (2009) 0.77
Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycins. Bioorg Med Chem Lett (2006) 0.77
Pyruvate-enriched resuscitation protects hindlimb muscle from ischemia-reperfusion injury. Mil Med (2010) 0.76
Dendritic cells are the major antigen presenting cells in inflammatory lesions of murine Mycoplasma respiratory disease. PLoS One (2013) 0.76
Low dose IL-15 induces snap arming of CD44(low) T lymphocytes in the absence of antigen. Cell Immunol (2008) 0.75
Regulation of perforin lysis: implications for protein disulfide isomerase proteins. Cell Immunol (2009) 0.75
Hydrolysis of tumor cell lipids after CTL-mediated death. Int Immunol (2009) 0.75
Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity. J Leukoc Biol (2009) 0.75